PT Jayamas Medica Industri Tbk (ISX:OMED) Total Equity: Rp2,851,734 Mil (As of Mar. 2026)


ISX:OMED PT Jayamas Medica Industri Tbk ISX:OMED
91 GF Score
Price Rp204.00
GF Value Rp237.70
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Jayamas Medica Industri Tbk Total Equity?

PT Jayamas Medica Industri Tbk ISX:OMED 91 Total Equity is Rp2,851,734 Mil as of Mar. 2026. GuruFocus rates ISX:OMED with a GF Score™ of 91/100 and a GF Value™ of Rp237.70 (Modestly Undervalued). The stock has 2 warning signs investors should review.

PT Jayamas Medica Industri Tbk's total equity for the quarter that ended in Mar. 2026 was Rp2,851,734 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PT Jayamas Medica Industri Tbk Total Equity Historical Data

* Premium members only.

The historical data trend for PT Jayamas Medica Industri Tbk's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Jayamas Medica Industri Tbk Total Equity Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 1,245,442.33 2,069,420.47 2,245,407.96 2,495,688.71 2,752,769.95

PT Jayamas Medica Industri Tbk Quarterly Data
Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,568,775.89 2,547,926.00 2,644,917.40 2,752,769.95 2,851,734.48
ISX:OMED
91GF Score
PT Jayamas Medica Industri Tbk ISX:OMED
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Jayamas Medica Industri Tbk Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PT Jayamas Medica Industri Tbk's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=3197846.92-445076.975
=2,752,770

PT Jayamas Medica Industri Tbk's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=3321884.497-470150.013
=2,851,734

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of Rp2,851,734 Mil mean?
PT Jayamas Medica Industri Tbk (ISX:OMED) has a Total Equity of Rp2,851,734 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for PT Jayamas Medica Industri Tbk and its competitors.
Is PT Jayamas Medica Industri Tbk's Total Equity too high?
PT Jayamas Medica Industri Tbk's current Total Equity is Rp2,851,734 Mil. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's Total Equity compare to ISRG and BDX?
PT Jayamas Medica Industri Tbk's Total Equity of Rp2,851,734 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for PT Jayamas Medica Industri Tbk and its competitors. PT Jayamas Medica Industri Tbk's current Total Equity is Rp2,851,734 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp237.70, compared to a current price of Rp204.00 — trading 14.2% below its estimated fair value. The current Total Equity is Rp2,851,734 Mil. PT Jayamas Medica Industri Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current Total Equity is Rp2,851,734 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?

Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued. The current stock price of Rp204.00 is trading 14.2% below its estimated GF Value™ of Rp237.70. GuruFocus considers PT Jayamas Medica Industri Tbk to be Modestly Undervalued.

Key valuation signals for ISX:OMED:

  • Total Equity: Rp2,851,734 Mil
  • GF Value™: Rp237.70 vs. price of Rp204.00 (14.2% below fair value)
  • GF Score™: 91/100 with 2 warning signs

No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Jayamas Medica Industri Tbk Business Description

Address Sebelah Selatan Jalan By Pass RT 05 / RW 01, Sidomojo Village, Krian District, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
91GF Score

Get the complete analysis for ISX:OMED

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp204.00
Price
Rp237.70
GF Value